FDA approved the Varipulse pulsed field ablation (PFA) platform for drug refractory paroxysmal atrial fibrillation, Johnson & ...

In a series of significant industry advancements, the U.S. FDA has given its nod to Johnson & Johnson's Varipulse device ...

Recent health news highlights include FDA approval for a Johnson & Johnson heart device, Canada's approval of Moderna's RSV ...

The device, Varipulse, is a pulsed field ablation system which uses small burns or freezes to cause some scarring in the ...

Irvine: Johnson & Johnson MedTech has announced the U.S. Food & Drug Administration (FDA) approval of the VARIPULSE Platform ...

The VARIPULSE™ Platform is the first and only Pulsed Field Ablation (PFA) System in the U.S. fully integrated with the CARTO™ ...

The technology is integrated with company’s electroanatomical mapping system, which helps guide operators during AF ablation.

FDA approves Johnson & Johnson's Varipulse for targeted atrial fibrillation treatment, enhancing precision and safety ...

Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...

Johnson & Johnson MedTech announced today that the FDA approved its Varipulse pulsed field ablation (PFA) platform for ...

Johnson & Johnson received Food and Drug Administration approval for its Varipulse pulsed field ablation (PFA) system, ...

PFA is a new cardiac ablation technique to treat a common heart arrhythmia. Traditional ablation methods use heat or cold to scar heart tissue, blocking irregular signals, but PFA uses electrical ...